Synthetic Biologics, Inc.
BETA-LACTAMASE FORMULATIONS
Last updated:
Abstract:
The present invention provides, in part, formulations comprising a beta-lactamase. Particularly, modified-release powder formulations comprising a beta-lactamase are provided which release a substantial amount of the beta-lactamase in the intestines. Therapeutic uses of the beta-lactamase formulations are also provided.
Status:
Application
Type:
Utility
Filling date:
20 Mar 2018
Issue date:
9 Apr 2020